Prag Goel has been appointed as the Vice President – Sales and Marketing at Alembic Pharmaceuticals, effective January 2025. In this leadership role, he will oversee the Megacare, Enteron, and Osteofit business divisions. With nearly three decades of experience in the pharmaceutical industry, Goel is a highly skilled professional known for driving business growth across diverse therapeutic areas.
Throughout his career, Prag Goel has gained expertise in various therapeutic fields, including Pediatrics, Cardiovascular, Diabetic, Anti-Infective, Gastrointestinal, Gynecology, Rheumatology, Anti-TB, Dermatology, and Critical Care. His extensive experience has enabled him to develop effective strategies in complex markets, consistently delivering impactful solutions. Goel is also recognized for his ability to build high-performance sales teams that meet and exceed business objectives.
Prior to his appointment at Alembic Pharmaceuticals, Goel held leadership roles at leading pharmaceutical companies such as Lupin Limited, Glenmark India Limited, Pfizer India Limited, and AstraZeneca Pharma India Ltd. His work in both Indian and multinational companies has provided him with a deep understanding of the pharmaceutical industry, which will be invaluable in strengthening Alembic’s position in the market.
In his new role, Goel’s leadership will be crucial to advancing the success of Alembic’s key business divisions. His focus on sales and marketing will help ensure the company continues to achieve its goals and expand its market share in these critical areas. Goel’s appointment reflects Alembic Pharmaceuticals’ commitment to growth and innovation in a competitive industry.
Prag Goel holds a B.Sc. from Kurukshetra University, a foundation that, combined with his vast industry experience, positions him to drive the company’s continued success. His appointment is a testament to Alembic’s dedication to strengthening its leadership team and achieving long-term growth.